Relation between the size of asymptomatic abdominal aortic aneurysms and levels of C-reactive protein in plasma;Relación del tamaño del aneurisma de aorta abdominal asintomático con los niveles plasmáticos de proteína C reactiva

Angiologia

Volumn 59, Issue 2, 2007, Pages 111-118

  De Haro Miralles, Joaquín ^a   Medina Maldonado, F J ^a   Martinez Aguilar E ^a   Florez Gonzalez A ^a   Varela Casariego, C ^a   Acin F ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

Aneurysm; Aorta; C reactive protein; Inflammation

Indexed keywords

PROTEIN C;

ABDOMINAL AORTA; ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD ANALYSIS; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATHOGENESIS; PATIENT MONITORING; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

EID: 44349164616     PISSN: 00033170     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-3170(07)75034-4     Document Type: Article

References (16)

1. Xu C, Zarins CK, Glagov S. Aneurysmal and occlusive atherosclerosis of the human abdominal aorta. J Vasc Surg 2001; 33: 91-6.
2. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, et al. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990; 137: 1199-213.
3. Shteinberg D, Halak M, Shapiro S, Kinarty A, Sobol E, Lahat N, et al. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg 2000; 20: 462-5.
4. Newman KM, Jean-Claude J, Li H, Ramey WG, Tilson MD. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 1994; 90: 224-7.
5. Treska V, Topolcan O, Pecen L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med 2000; 38: 1161-4.
6. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjala H, et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997; 17: 2843-7.
7. De Haro J, Acín F, Medina FJ, March JR, Utrilla F, López-Quintana A. Plasma concentration of C-reactive protein and severity of peripheral arterial disease. Congreso Internacional de Angiología y Cirugía Vascular. Madrid, 2004.
8. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon. Circulation 1999; 100: 96-102.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
10. Powell JT, Muller BR, Greenhalgh RM. Acute phase proteins in patients with abdominal aortic aneurysms. J Cardiovasc Surg (Torino) 1987; 28: 528-30.
11. Bohórquez-Sierra JC, Doia-Artazcoz E, Ocaña E, Craven-Bartle A, Rodríguez-Piñero M, Bohórquez-Sierra C. Proteína C reactiva como factor pronóstico de mortalidad en los aneurismas rotos. Angiología 2005; 57: 225-36.
12. Domanovits H, Schillinger M, Mullner M, Holzenbein T, Janata K, Bayegan K, et al. Acute phase reactants in patients with abdominal aortic aneurysm. Atherosclerosis 2002; 163: 297-302.
13. Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998; 12: 137-44.
14. Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 2004; 110: 862-6.
15. Ridker PM. Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet 2001; 358: 946-8.
16. Rothkrantz-Kos S, Schmitz MP, Bekers O, Menheere P, Van Dieijen-Visser MP. High-sensitivity C-reactive protein methods examined. Clin Chem 2002; 48: 359-62.